alexa Equilibrium Binding Interactions Between Lotrafilcon A Soft Contact Lenses And The Two Prostaglandin Anti-glaucoma Drugs Bimatoprost And Tafluprost
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th International Conference on Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Richard A. Kenley, Helena Filippone, Mai Giske, DanBeidler, Joseph Vehige and Jeffrey Fleitman
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.017
Abstract
Objectives: To determine equilibrium binding constant (EB) values for bimatoprost and tafluprost drug product formulations in contact with Lotrafilcon A soft contact lenses and to characterize the importance of drug molecule hydrophobicity in controlling binding interactions Methods: Bimatoprost Ophthalmic Solution and Tafluprost Ophthalmic Solution (Saflutan?) drug product solutions were incubated with Lotrafilcon A lens material for timed intervals at 25 and 37 ?C. Aliquots were withdrawn, filtered and tested by RP-UPLC with respect to [bimatoprost] or [tafluprost] remaining in solution. A series of homologous dialkyl phthalate esters and a series of homologous p-hydroxybenzoic acid alkyl esters were also tested as reference compounds. Results: Bimatoprost and tafluprost were both rapidly (within 15 min) absorbed from solution by Lotrafilcon A lenses, reaching equilibrium within 60 min. At any lens:solution(w/v) ratio, the extent of drug binding to lens material was greater for tafluprost than for bimatoprost. The log(EB) values correlated with solute octanol:water partition coefficient (logP) values, indicating that hydrophobic interactions are important in controlling solute partitioning into the lens material. Conclusions: This study established quantitative relationships for tafluprost and bimatoprost binding to Lotrafilcon A lenses. The fraction of either bimatoprost or tafluprost that binds to Lotrafilcon A increases with increasing lens:solution (w/v) ratio. For a 60-?L dose volume applied to a single contact lens, 16% of initially-present bimatoprost remains in solution, whereas only 6% of initially-present tafluprost remains in solution.These calculations clearly demonstrate that both drugs partition very extensively into Lotrafilcon A contact lens material. Although the clinical implications of such binding can only be surmised, it would seem prudent to caution contact lens wearers to remove the lenses before administering either prostaglandin drug.
Biography
Richard Kenley, Ph.D. (Advantar founder and CEO), has over 30 years experience in the pharmaceutical, biotechnology, and bio-pharma contract service industries. He is an inventor on 4 patents, author of over 60 peer-reviewed scientific publications. Dr. Kenley has made major contributions to the development and eventual approval of important pharmaceuticals including: butaconozole, nafarelin (Synarel?), bone morphogenetic protein 2 (InFuse?), rhIL-11 (Neumega?), pramlintide (Symlin?), and exenatide (Byetta?). His industry assignments include senior management positions at SRI International, Syntex, Baxter, Genetics Institute (Pfizer), Amylin (Astra-Zeneca), and Cabrillo Laboratories (Catalent).
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]ine.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords